Class IC Drugs in Cardiomyopathy

Peter R. Kowey, Farah M. Olleik

Open source

DOI
10.1016/j.jacep.2024.03.009
Published
2024-05
Container
JACC: Clinical Electrophysiology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacep.2024.03.009,
  title = {Class IC Drugs in Cardiomyopathy},
  author = {Peter R. Kowey and Farah M. Olleik},
  year = {2024},
  journal = {JACC: Clinical Electrophysiology},
  doi = {10.1016/j.jacep.2024.03.009},
  url = {https://doi.org/10.1016/j.jacep.2024.03.009}
}

RIS

TY  - JOUR
TI  - Class IC Drugs in Cardiomyopathy
AU  - Peter R. Kowey
AU  - Farah M. Olleik
PY  - 2024
JO  - JACC: Clinical Electrophysiology
DO  - 10.1016/j.jacep.2024.03.009
UR  - https://doi.org/10.1016/j.jacep.2024.03.009
ER  - 

APA

Kowey, P. R., & Olleik, F. M. (2024). Class IC Drugs in Cardiomyopathy. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2024.03.009

Source records